NCT04705415View on ClinicalTrials.gov

A Single and Multiple Ascending Dose Study of Niclosamide in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

November 17, 2020

Primary Completion Date

October 13, 2021

Study Completion Date

October 28, 2022

Conditions
Healthy
Interventions
DRUG

Niclosamide

Niclosamide is an antihelmintic with in-vitro antiviral activity

DRUG

Placebo

Matching hydroxypropylmethylcellulose HPMC capsules with no active ingredients

Trial Locations (1)

90630

WCCT Global Inc., Cypress

Sponsors
All Listed Sponsors
lead

NeuroBo Pharmaceuticals Inc.

INDUSTRY